Mediator complex components are frequent targets for genetic alterations in various types of human cancer

Libin Deng; Cheng Zhang; Duling Miao; Xiaoli Tang; Shiwen Luo; Hong-Bo Xin; Huidong Shi

doi:10.1016/j.jgg.2017.08.006

Volume 44 Issue 12

Dec. 2017

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2017 > 44(12): 587-591

PDF( 924 KB)

Mediator complex components are frequent targets for genetic alterations in various types of human cancer

doi: 10.1016/j.jgg.2017.08.006

Libin Deng^{1, 2},
Cheng Zhang³,
Duling Miao⁴,
Xiaoli Tang⁵,
Shiwen Luo^{6, 7},
Hong-Bo Xin⁸,
Huidong Shi^{9, 10}

1
Institute of Translational Medicine, Nanchang University, Nanchang 330031, China
2
Medical School of Nanchang University, Nanchang 330031, China
3
Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China
4
Institute of Translational Medicine, Nanchang University, Nanchang 330031, China
5
Medical School of Nanchang University, Nanchang 330031, China
6
Medical School of Nanchang University, Nanchang 330031, China
7
Center for Experimental Medicine, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China
8
Institute of Translational Medicine, Nanchang University, Nanchang 330031, China
9
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
10
Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA

More Information

Corresponding author: E-mail address: denglb1937@163.com (Libin Deng); E-mail address: hshi@augusta.edu (Huidong Shi)
Received Date: 2017-04-18
Accepted Date: 2017-08-25
Rev Recd Date: 2017-07-26

Available Online: 2017-11-23

Publish Date: 2017-12-20

Abstract

FullText(HTML)

References(20)

References

[1]	Allen, B.L., Taatjes, D.J. The Mediator complex: a central integrator of transcription Nat. Rev. Mol. Cell Biol., 16 (2015),pp. 155-166
[2]	Cani, A.K., Hovelson, D.H., McDaniel, A.S. et al. Mol. Cancer Res., 13 (2015),pp. 613-619
[3]	Cerami, E., Gao, J., Dogrusoz, U. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data Cancer Discov., 2 (2012),pp. 401-404
[4]	Chapuy, B., McKeown, M.R., Lin, C.Y. et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma Cancer Cell, 24 (2013),pp. 777-790
[5]	Chipumuro, E., Marco, E., Christensen, C.L. et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer Cell, 159 (2014),pp. 1126-1139
[6]	Christensen, C.L., Kwiatkowski, N., Abraham, B.J. et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor Cancer Cell, 26 (2014),pp. 909-922
[7]	Clarke, P.A., Ortiz-Ruiz, M.-J., TePoele, R. et al. Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases eLife, 5 (2016)
[8]	Dehainault, C., Garancher, A., Castera, L. et al. Hum. Mol. Genet., 23 (2014),pp. 5243-5250
[9]	Jiang, Y.Y., Lin, D.C., Mayakonda, A. et al. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma Gut, 66 (2017),pp. 1358-1368
[10]	Kampjarvi, K., Kim, N.H., Keskitalo, S. et al. Prostate, 76 (2016),pp. 22-31
[11]	Kampjarvi, K., Park, M.J., Mehine, M. et al. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas Hum. Mutat., 35 (2014),pp. 1136-1141
[12]	Kandaswamy, R., Sava, G.P., Speedy, H.E. et al. Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism Cell Rep., 16 (2016),pp. 2061-2067
[13]	Lim, W.K., Ong, C.K., Tan, J. et al. Nat. Genet., 46 (2014),pp. 877-880
[14]	Mansour, M.R., Abraham, B.J., Anders, L. et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element Science, 346 (2014),pp. 1373-1377
[15]	Pelish, H.E., Liau, B.B., II, Nitulescu, Tangpeerachaikul, A. et al. Mediator kinase inhibition further activates super-enhancer-associated genes in AML Nature, 526 (2015),pp. 273-276
[16]	Pott, S., Lieb, J.D. What are super-enhancers? Nat. Genet., 47 (2015),pp. 8-12
[17]	Spaeth, J.M., Kim, N.H., Boyer, T.G. Mediator and human disease Semin. Cell Dev. Biol., 22 (2011),pp. 776-787
[18]	Turunen, M., Spaeth, J.M., Keskitalo, S. et al. Cell Rep., 7 (2014),pp. 654-660
[19]	Yin, J.-W., Wang, G. The Mediator complex: a master coordinator of transcription and cell lineage development Development, 141 (2014),pp. 977-987
[20]	Zhang, Z., Peng, H., Wang, X. et al. Preclinical efficacy and molecular mechanism of targeting CDK7-dependent transcriptional addiction in ovarian cancer Mol. Cancer Ther., 16 (2017),pp. 1739-1750